NeutriSci International Inc. announced a non-brokered private placement of up to 12,500,000 units at a price of CAD 0.02 per unit for gross proceeds of up to CAD 250,000 on November 23, 2022. Each Unit will consist of one common share and one common share purchase warrant, with each warrant entitling the holder to acquire an additional common share of the Company at a price of CAD 0.05 for a period of twenty-four months from the date of issuance. All securities issued in connection with the Financing will be subject to a four-month-and-one-day statutory hold period from the date of issuance.

Closing of the transaction and completion of any remains subject to the receipt of all regulatory approvals, including the approval of the TSX Venture Exchange.